Skip to main content
. 2022 Feb 11;13(7):977–985. doi: 10.1111/1759-7714.14341

TABLE 2.

Tumor characteristics according to interstitial lung abnormality scoring

Characteristics ILA score
0 or 1 (n = 209) 2 (n = 45) Total (n = 254) p‐value
Location 0.02
Nonlower lobe 134 (64.1) 21 (46.7) 155 (61.0)
Lower lobe 75 (35.9) 24 (53.3) 99 (39.0)
Location (laterality) <0.001
Inner one‐third 36 (17.2) 6 (13.3) 42 (16.5)
Middle one‐third 100 (47.8) 10 (22.2) 110 (43.3)
Outer one‐third a 73 (34.9) 29 (64.4) 102 (40.2)
T stage b 0.08
1 (≤30 mm) 122 (58.4) 18 (40.0) 140 (55.1)
2a (>30 mm, ≤40 mm) 48 (22.9) 13 (28.9) 61 (24.0)
2b (>40 mm, ≤50 mm) 30 (14.4) 9 (20.0) 39 (15.4)
3 (>50 mm, ≤70 mm) 9 (4.3) 5 (11.1) 14 (5.5)
Tumor size (mm) b 25.0 (16.0, 35.0) 30.0 (21.0, 40.5) 25.5 (17.8, 35.0) <0.001
N stage 0.37
0 194 (92.8) 40 (88.9) 234 (92.1)
1 15 (7.2) 5 (11.1) 20 (7.9)
Histology <0.001
Non‐SQC 178 (85.2) 26 (57.8) 204 (80.3)
SQC 31 (14.8) 19 (42.2) 50 (19.7)
Lung cancer stage c <0.001
Stage I 175 (83.7) 26 (57.8) 201 (79.1)
Stage II 34 (16.3) 19 (42.2) 53 (20.9)

Note: Continuous variables are presented as median values (interquartile range). Values for the number of patients are presented as numbers and percentages (in parenthesis). Bold values indicate that p < 0.05.

Abbreviations: ILA, interstitial lung abnormality; SQC, squamous cell carcinoma.

a

Significant differences considering Bonferroni's correction for post hoc analysis.

b

By the eighth TNM staging.

c

Maximal tumor diameter.